Importantly, targeting PI3Kγ in myeloid cells by small molecule inhibitors shifts tumor-infiltrating macrophage toward the M1 subtype and enhances CD8+T cell population as well as the ratio of CD8+/Treg in a murine model of melanoma [38]. Here, CD8A is linked to neoplasm.